Numbing (menthol) NDC 85524-2605

NDC codes

FDA NDC Directory

Product NDC (as listed)85524-2605Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85524-2605Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85524-2605-2	85524260502	1 BOTTLE in 1 BOX (85524-2605-2) / 60 mL in 1 BOTTLE (85524-2605-1)Marketed from Mar 28, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Numbing
Generic name (nonproprietary): menthol
Active ingredients: Menthol — 3 g/100mLMethyl salicylate — 10 g/100mL
Dosage form: Cream
Route: Topical
Labeler: FlexiGo Inc
Product type: Over-the-counter drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022029
Marketing start: Mar 28, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 85524-2605_4ce416dd-2431-4648-e063-6294a90ab199SPL ID 4ce416dd-2431-4648-e063-6294a90ab199SPL set ID 4ce416dd-2430-4648-e063-6294a90ab199RxCUI 1486874UNII L7T10EIP3A, LAV5U5022Y

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485524260502 followed by a unit qualifier and the quantity

Package 85524-2605-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 13, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE SECTION

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022029

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022029
Product	Strength	Form · route	Labeler	Product NDC
Salonpas Arthritis Painmenthol, methyl salicylate	Menthol 31.5 mg/1; Methyl salicylate 105 mg/1	PatchPercutaneous, Topical, Transdermal	Hisamitsu Pharmaceutical Co., Inc.	46581-680
Salonpas Pain Reliefmenthol, methyl salicylate	Menthol 31.5 mg/1; Methyl salicylate 105 mg/1	PatchPercutaneous, Topical, Transdermal	Hisamitsu Pharmaceutical Co., Inc.	46581-670
Salonpas Pain Reliefmenthol, methyl salicylate	Menthol 63 mg/1; Methyl salicylate 210 mg/1	PatchPercutaneous, Topical, Transdermal	Hisamitsu Pharmaceutical Co., Inc.	46581-675
Salonpas Arthritis Painmenthol, methyl salicylate	Menthol 63 mg/1; Methyl salicylate 210 mg/1	PatchPercutaneous, Topical, Transdermal	Hisamitsu Pharmaceutical Co., Inc.	46581-685